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Abstract: Mass spectrometry-based proteomics is a powerful tool for identifying and quantifying
proteins in biological samples. While it is routinely used for the characterization of simple cell line
systems, the analysis of the cell specific proteome in multicellular organisms and tissues poses a
significant challenge. Isolating a subset of cells from tissues requires mechanical and biochemical
separation or sorting, a process which can alter cellular signaling, and thus, the composition of
the proteome. Recently, several approaches for cell selective labeling of proteins, that include
bioorthogonal amino acids, biotinylating enzymes, and genetic tools, have been developed. These
tools facilitate the selective labeling of proteins, their interactome, or of specific cell types within a
tissue or an organism, while avoiding the difficult and contamination-prone biochemical separation of
cells from the tissue. In this review, we give an overview of existing techniques and their application
in cell culture models and whole animals.
Keywords: quantitative proteomics; stable isotope labeling; tissue; amino acid analog; biotinylation;
bioorthogonal; multicellular; SILAC; APEX; BioID
1. Introduction
Higher organisms are composed of different cells, allowing the individual cell to specialize, and
thus become more efficient in performing specific tasks. The coordination of biological functions
requires complex signaling events, and consequently, the proteomes of cells in a heterogeneous
community will differ from the proteomes of cells that are kept in monocultures. The analysis of these
complex intercellular communication systems poses a significant challenge to modern cell biology
and biochemistry. Only recently, methods have been developed which are capable of addressing this
issue. The use of engineered enzymes and bioorthogonal amino acids, in combination with other
chemical compounds, now allows the analysis of multicellular environments in a cell or tissue specific
manner. In this review, we are focusing on the methods that have been successfully applied in the field
of proteomics.
2. Mass Spectrometry-Based Proteomics
Over the last few years, mass spectrometry-based proteomics has become one of the main
techniques for the analysis of proteomes on a large scale. The development of new instruments, and in
parallel, new procedures for sample preparation, have pushed the technique to new horizons, with
the depth of the analysis and throughput constantly increasing. The first comprehensive analysis of
the yeast proteome was reported in 2008 [1], and with state-of-the art technology, this benchmark can
now be reached with a very limited analysis time of one hour [2]. The complete analysis of the human
proteome, although not reached yet, is not far away, as current literature reports the identification of
around 10,000 proteins in HeLa cells [3].
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Quantification of changes between proteomes is one of the main goals and challenges addressed by
mass spectrometry-based proteomics. Several isotope-based labeling techniques have been developed
and utilized in the past. While some of them introduce the label using chemical modification, the use
of stable isotope labeling by amino acids in cell culture (SILAC) has been proven to be a very useful
and robust method for the labeling of proteins in cell culture [4]. The basis for this labeling technique
is the stepwise replacement of essential or conditionally essential amino acids (typically lysine and
arginine) by an isotope-labeled analog in cell culture (Figure 1—labeling techniques). The labeled cells
can then be combined prior to lysis, and processed together. The resulting light and heavy peptides
generate characteristic mass pairs in the precursor mass detection, and the direct comparison of the
two peptide intensities enables relative quantification of the peptides and the proteins they originate
from. SILAC is widely used in cell culture, but is also applicable for labeling whole model organisms,
including mammals [1,5,6]
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Figure 1. Amino acid based labeling techniques. (A) SILAC labeling. Proteins are metabolically
labeled in cell culture with isotope-coded amino acids (typically lysine or arginine, light (L)/heavy
(H)). All unlabeled lysine and arginine is removed and replaced with the isotope labeled counterpart
(yellow dish). The two cultures are now combined and jointly prepared for mass spectrometric analysis.
In the mass spectra, the isotope labeled peptides give rise to a double peak–SILAC pair (L and H), from
which the peptide and protein abundance ratios can be inferred. (B) Dynamic labeling with SILAC
amino acids. At the start point of the experiment (t0) the media is switched from unlabeled to labeled.
All proteins synthesized after this time point are isotopically labeled. This corresponds to an increasing
peak in the mass spectra for the labeled peptides (yellow peaks). Samples are collected at different time
points, allowing the analysis of the changes in protein synthesis.
Although very robust, this method has significant shortcomings in the analysis of proteomes
from different cell types in co-culture. Pre-labeled cells, when transferred to media with another
label, dilute the signal as they divide and synthesize new proteins, but for short incubations, this
method has been successfully used [7,8]. In the trans-SILAC approach, differentially labeled cells are
co-cultivated for some time and subsequently sorted back into homogeneous populations with FACS
(Fluorescence-activated cell sorting). The two populations are then analyzed for proteins which have
been transferred (trans-SILAC) between the different cell types during co-culturing [8].
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To achieve complete labeling of the proteome, cells should be cultivated for at least five doubling
times in SILAC media. Differentially labeled proteomes (“heavy”, “medium-heavy” and/or “light”)
can be directly combined and compared with a single analysis, but it is also possible to expose cells to
SILAC media for a limited amount of time (pulsed SILAC, Figure 1B) and thereby investigate changes
in protein synthesis [9–11]. Due to the lack of enrichment strategies for SILAC, the low abundance
of newly synthesized proteins hampers identification and quantification in experiments with short
pulses. If the SILAC pulse is continued for a prolonged amount of time, the method is sometimes also
referred to as dynamic SILAC, which is focused on the quantification of protein turnover after a certain
stimulus [12], and has also been successfully used in mice [13].
3. Bioorthogonal Amino Acids
There are several bioorthogonal amino acids available for metabolic labeling. These amino acid
analogues are either coupled to tRNA by endogenous tRNA synthetases [14–17], or by modified
tRNAs synthetases [18–21] that need to be genetically transferred to the model organism or cell line of
choice. The unnatural amino acids (UAA) often contain a functional group that can be linked to an
affinity tag for enrichment, or a fluorescent probe for imaging. Bioorthogonal non-conanonical amino
acid labeling (BONCAT) overcomes the limitations of SILAC regarding cell specificity and possibility
for enrichment.
4. Enrichment Using High Affinity or Covalent Binding
Classical biochemical and cell-biological preparation methods allow the isolation of subcellular
compartments and cells of a particular cell type, the method spectrum ranging from differential
centrifugation and general chromatography techniques to affinity enrichment. However, all these
methods are hampered by the same challenges: the significant amount of starting material needed,
and the high level of cross contamination with other parts of the cell. For cell biological enrichment
techniques, the problem of cross contamination is highly dependent on the method, and while FACS
allows a rather high purity, affinity purification based techniques can include significant amounts of
non-targeted cells. FACS generates high quality samples, but the protein amounts from cells that can
be sorted are rather small, and require significant sorting times at the machine. If whole tissues are
analyzed, the technique requires dissociation of the tissue and generation of a single cell suspension,
which by itself can pose a challenge and induce proteomic changes in the analyzed cells.
An alternative approach is the introduction of high affinity binding groups at the cellular or
subcellular level, with the small molecule biotin often being the tag of choice. As a small molecule,
it is able to penetrate tissue and diffuses easily to different parts of the cell. Biotin ligating enzymes
link biotin to the target protein, and the labeled protein can then be isolated using the extremely high
affinity of avidin (Kd ≈ 10−15 mol/L) or streptavidin beads (Kd ≈ 10−14 mol/L) for biotin. Another
possibility to bind labeled proteins specifically is a covalent bond. In that case, a specific amino acid
analogue has to be introduced into the protein. These modified amino acids contain either an azide or
an alkyne group as a side chain. One of the special properties of azides and alkynes is the ability to
form a ring structure (cyclo-addition) in the presence of a catalyst (click chemistry, Figure 2). As shown
in Figure 2, the formation of this covalent bond can be induced after the denaturing lysis of cells
and tissues, binding the proteins covalently to the resin of choice through an efficient, high yield
reaction [22]. Covalent capture permits much harsher washing protocols, and thereby minimizes
the background.
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Figure 2. Covalent binding of proteins using bioorthogonal amino acids. (A) Azidohomoalanine
(AHA). (B) AHA labeled proteins are bound by cyclo-addition in the presence of Cu(I) to a resin
containing an alkyne residue. (C) homopropargylglycine (HPG). (D) HPG labeled proteins are bound
by cyclo-addition to a resin containing an azide group.
5. Azidohomoalanine and Homopropargylglycine
The methionine analogues azidohomoalanine (AHA) and homopropargylglycine (HPG) are able
to bind to the endogenous methionyl-tRNA synthetase (MetRS), and are thus incorporated into proteins
in the place of methionine [14–16]. AHA and HPG carry an azide or an alkyne group, respectively that
enables covalent binding to a resin bound tag for enrichment or a fluorescent tag for imaging via click
chemistry. The affinity of AHA and HPG to MetRS is 390–500 fold lower than the one of methionine,
and it is advisable to perform the labeling in methionine free media after a methionine depletion
step [23]. However, it has been shown that a 24 h long AHA pulse in methionine-free media induces
substantial protein abundance differences. Supplementing media with both AHA and methionine
in a ratio of 30:1 minimized the effect, but also compromised the number of identified proteins [24].
Despite the lower affinity of AHA and HPG to MetRS compared to methionine, several studies have
demonstrated that these UAAs are also incorporated into proteins in vivo, in zebrafish, frog, and mice,
and do not affect embryonic development [17,25–27]. The possibility for enrichment makes short
labeling times (pulses) feasible, and predisposes the technique for investigating newly synthesized
proteins and proteome dynamics [28–30]. Labeling with AHA and SILAC has also been combined
to analyze newly synthesized and secreted proteins in activated macrophages [31], and to measure
translation profiles in brain slices [32].
6. Modified Aminoacyl tRNA Synthetases
Cell selective tagging of proteins with UAAs has become possible by the combination of
engineered tRNA synthetases, and UAAs that are recognized by the mutant tRNA synthetases but are
only poor substrates for endogenous enzymes. In 2006, the Tirell lab reported a mutant Escherichia coli
MetRS that is capable of coupling the methionine surrogate azidonorleucine to methionyl-tRNA [19].
Importantly, the azide group of azidonorleucine enables enrichment of labeled proteins by click
chemistry. Azidonorleucine incorporation into proteins is limited to cells that express the mutant
synthetase, and the approach has been used by several studies to differentially label proteins originating
from pathogens and host cells during bacterial infection [18,33,34]. The mutant MetRS approach was
further developed into a two-step activatable system, based on the construction of a split MetRS that
generates a translational output only in cells in which inputs from two promoters are on at the same
time, enabling fine tuning of the labeling [35]. A mutant MetRS was also introduced into mammalian
cells, but drawbacks of the method are that only N-terminal methionines are labeled, and that the
mutant MetRS activated methionine four times faster than azidonorleucine [36,37].
Proteomes 2017, 5, 17 5 of 15
Recently, labeling with azidonorleucine has been adapted for usage in Drosophila melanogaster [20],
by mutating a single amino acid residue within the MetRS binding pocket from D. melanogaster,
and expressing the mutated enzyme under cell specific promoters. Importantly, internal methionine
residues can also be labeled with this method. The investigators note that prolonged labeling throughout
all developmental stages affected larval growth, but no effect was observed when labeling was restricted
to a period of 48 h [20].
Cell specific labeling with UAAs is also possible in Caenorhabditis elegans. Using a mutant
phenylalanyl-tRNA synthetase allows the charging of phenylalanyl-tRNA with the noncanonical
amino acid p-azido-L-phenylalanine. The mutant enzyme is selective for p-azido-L-phenylalanine,
and starvation of phenylalanine is not required. Cell selective expression of the synthetase and reacting
the azide group of the UAA with a fluorescent or enrichment tag (click chemistry) enable enrichment
or visualization of tissue specific proteins [38].
In stochastic orthogonal recoding of translation with chemoselective modification (SORT-M),
an orthogonal aminoacyl-tRNA synthetase/tRNA pair is introduced into cells. The anticodon of
the orthogonal tRNA can be engineered to recognize different sets of sense codons, and there is
no competition at the active site of the synthetase by natural occurring amino acids. It is therefore
possible to perform the labeling in rich media or with a normal diet supplemented with the UAA.
Labeling is feasible in a variety of cell types and organisms, and did not affect oocyte development
in D. melanogaster [21]. SORT-M was successfully combined with enrichment of tagged proteins
(SORT-E) by reacting a cyclopropene-containing bioorthogonal amino acid and a tetrazine-biotin
probe with a cleavable linker. The results demonstrate that SORT-E is applicable for cell specific
proteomics, but the authors note that tagging at different codons led to overlapping, but distinct, sets
of proteomes, and suggest tagging at more than one codon for increased proteome coverage [39]. SORT
has already been applied in the brain of live mice, and can be expanded to contain UAAs that mimic a
posttranslational modification [40,41].
A similar approach can be used to isolate specified proteins of interest without the need for an
enrichment tag that could interfere with secondary structure and function of the protein. In click-MS,
a construct containing the protein of interest with an amber (TAG) stop codon [42] is introduced into
the host cell together with a modified tRNA and tRNA synthetase. The UAA p-azido-L-phenylalanine
is then selectively incorporated into the protein at the place of the amber codon, and the protein is
subsequently enriched via click chemistry [43].
7. Isotopic Labeling of Amino Acid Precursors (CTAP and NANCAT)
Cell selective labeling with amino acid precursors (CTAP) avoids the problems that might arise
from structural differences of bioorthogonal amino acids. Lysine is an essential amino acid for
vertebrate cells, but can be synthesized by plants, bacteria, and lower eukaryotic organisms. By genetic
incorporation of lysine synthesizing enzymes (lysine racemase or diaminopimelate decarboxylase),
and isotope labeling of their substrates (D-lysine or 2,6-diaminopimelic acid, respectively), heavy
lysine labeling of cells that express the transgene can be achieved [44]. Tape et al. have optimized
the original protocol and showed that labeling efficiency is comparable to SILAC [45]. CTAP can be
used to differentially label proteins from distinct cell types in co-culture, and has been combined
with phosphoproteomics to dissect KRAS dependent signaling between pancreatic tumor and
stromal cells [46].
Nitrilase-activatable non-canonical amino acid tagging (NANCAT) exploits a similar strategy
that is based on the enzymatic conversion of nitrile-substituted precursors to their corresponding
non-canonical amino acids AHA or HPG [47]. Labeled proteins can be enriched with click chemistry,
but unlike CTAP, the NANCAT system does not allow the introduction of two different labels for cells
in co-culture.
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8. Genetic Labeling
8.1. O-Propargyl-Purocmycin Labeling (OP-Puro)
OP-Puro labeling has originally been developed for fluorescence imaging of protein synthesis.
The puromycin analogue OP-Puro binds to the acceptor site of translating ribosomes and forms a
covalent bond between the C-terminus of the nascent polypeptide chain and the primary amine group
of OP-Puro. Labeled newly synthesized proteins can be enriched, or visualized, by reacting the alkyne
group of OP-Puro with a biotin-azide or with a fluorescent azide respectively [48]. The technique
was further modified by adding a labile blocking group to OP-Puro, which can be removed by the
E. coli enzyme, penicillin G acylase. Cell selective labeling and enrichment of actively translated
polypeptides can be accomplished by targeted expression of the enzyme. This technique requires very
short labeling times, and provides a snapshot of newly synthesized proteins in a subset of cells at a
certain time point [49].
8.2. Specific Labeling with Biotin
In vivo labeling of specific proteins is a powerful tool to monitor the fate of proteins, or changes
to their localization. One system that allows the tissue specific labeling of individual proteins in
different tissues is the expression of the E. coli derived biotin-ligase, BirA, in combination with the
tagging of the gene of interest with a specific amino acid sequence, the so called BirA- or Avi-tag.
The BirA ligase recognizes the tag and adds a biotin onto the tag (Figure 3C), which can then be used
for isolation of the protein, or labeling for microscopy. If the expression of the biotin ligase is restricted
to specific tissues, the BirA system can be used to identify tissue specific complex formation. Using
this technique, the neuron specific interaction of DLG-1 and MAPH-1.1 in C. elegans was identified in a
study comparing complex composition in four different cell types in vivo [50].
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Figure 3. Biotin based in vivo labeling techniques. (A) BioID method. The protein of interest is
expressed as a fusion protein with the BioID biotin ligase. The BioID ligase transfers biotin to interacting
proteins in proximity to the protein of interest. Using high affinity binding resins, the biotinylated
proteins are isolated, digested, and analyzed by mass spectrometry. (B) APEX. The protein of interest
is expressed as a fusion protein with the APEX enzyme. In the presence of biotin–phenol and H2O2,
the APEX enzyme transfers biotin to the interacting proteins. The biotinylated proteins are isolated
and analyzed. (C) Avi- or BirA-tag. The protein of interest is fused to the Avi tag. The coexpressed
BirA biotin ligase transfers biotin to the Avi-tag. High affinity chromatography is used to isolate the
in vivo biotinylated protein of interest and its interactors. The protein of interest and the interactors
are igested and analyzed by mass spectrometry. (D) Labeling of a specific cell type in C. elegans.
By expressing the APEX enzyme under the control of a tissue specific promoter, only the roteins in a
subpopulatio of cells are labeled with bioti . Aft r extraction of the whole prot om , labeled proteins
can b easily purified and analyzed.
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8.3. Unspecific Labeling with Biotin
The promiscuous biotin ligase from E. coli has been successfully used in protein–protein interaction
studies (BioID [51]). For this, the biotin ligase has been fused to the protein of interest and expressed in
the cell, leading to the biotinylation of interacting proteins that are physically close to the biotin ligase.
The biotinylated proteins are then isolated by avidin-based precipitation techniques and identified
by mass spectrometry (Figure 3A). Since this approach is based on a genetic construct that generates
a fusion protein with the biotin ligase, it can be used for the specific labeling of interacting proteins
in selected tissues. This is achieved by combining the expression of the fusion protein with a tissue
specific promoter, allowing only the expression in a subset of cells in the tissue. After labeling of
the interacting partners, the proteins of the tissue are extracted by standard techniques, and the
biotinylation is detected by mass spectrometry [52]. Recently, an improved version of the BioID ligase
has been developed, which is smaller in size, and more efficient in transferring biotin to its targets [53].
However, labeling with BioID remains rather slow, requiring labeling times of around 24 hr.
An alternative method for labeling interacting proteins, or proteins in a particular subcellular
compartment, is the use of APEX, an engineered enzyme derived from soy or pea ascorbate
peroxidase [54,55]. The APEX enzyme is engineered to be targeted to a specific compartment [54] or a
specific cell type. The live cells are then treated for a very short time (~1 min) with hydrogen peroxide
in the presence of biotin–phenol. This generates highly reactive biotin–phenol radicals that react with
proteins in their vicinity. Since the reaction is driven by intermediate radicals, the labeling reaction is
very rapid. The biotin tag can again be used for the purification of the labeled proteins and subsequent
mass spectrometric analysis (Figure 3B). Since the original APEX has some limitations, in terms of
stability to heat and a reducing environment, an improved APEX2 enzyme has been engineered [56].
The specific expression of mitochondrion-localized APEX in different fly tissues was used to compare
the mitochondrial composition in different tissues [57], or to analyze the specific proteomes in different
tissues of C. elegans [58] (Figure 3D).
8.4. GFP-Labeling of a Subpopulation of Cells Combined with FACS
Expression of GFP under a cell specific reporter, followed by FACS sorting of the cells, enables
enrichment of the respective cell type or tissue for proteomics. Palma et al. report the colon stem cell
specific proteome from a recombinant mice strain that expresses GFP under the lineage specific Lgr5
promoter [59]. A similar approach is also applied in analyzing the proteome of sub-populations of
prokaryotic cultures, and is reviewed here [60].
9. Analysis of Cell and Tissue Specific Signaling
9.1. Tyrosine Signaling
In order to address the signaling changes in response to ephrin (Eph) receptor ligand interaction,
the laboratory of Tony Pawson used a combination of SILAC and cells expressing either Eph or
the receptor (quantitative analysis of Bidirectional Signaling—qBidS). Cells expressing Eph were
labeled with one type of label, while the receptor expressing cells were labeled with the other type
of SILAC label. After incubating the two populations together for 10 min, the cells were lysed, and
phospho-tyrosine peptides isolated and analyzed by mass spectrometry. The SILAC label could trace
the signal back to the either the Eph or Eph-receptor expressing cells, allowing the construction of a
specific signaling network for both sides of a cell-to-cell signaling system [7].
9.2. Bio-Ubiquitin
An elegant example for the use of tissue specific promoters for tissue specific labeling, is the
use of bio-Ubiquitin in ubiquitination assays. Ubiquitin is a signaling molecule which is involved in
different types of cellular signaling, including specific degradation, bulk degradation, stabilization of
proteins, or DNA repair. Like other post-translational modifications, the labeling of substrate proteins
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is performed by an enzymatic cascade, which uses ATP to catalyze the covalent attachment of the
C-terminus of ubiquitin to the amino group of lysine side chain, or the N-terminus of a protein [61].
Ubiquitin itself is a protein, and thus has to be synthesized prior to its use in the cell. Ubiquitin is
expressed in the form of several N-terminal fusion proteins. These fusion proteins are proteolytically
processed, co-translationally creating the mature ubiquitin protein, which is recognized by the
conjugating enzymatic cascade. For the tissue-specific detection of ubiquitin labeling, the precursor of
ubiquitin is fused to a BirA tag (Avi tag). The sequence of the BirA tag is recognized by the sequence
specific biotin ligase BirA, and biotinylated (Figure 4). By combining the expression of the precursor
and the ligase with a tissue specific promoter, the ubiquitination reaction can only occur in selected
tissues. After a biotin -specific isolation, bio-ubiquitin modified proteins can be identified by mass
spectrometry [62–65]. An alternative approach has recently been developed using an N-terminally
tagged ubiquitin in combination with transcriptional repression of two of the four ubiquitin genes
(StUbEx). This allowed an 80% replacement of the cellular ubiquitin with the tagged version, but
had some impact on the transcription on the UBA52 ubiquitin gene, which is also responsible for the
production of the ribosomal protein L40 [66].
BirA tag
BirA tag ubiquitin
BirA tag ubiquitin BirA tag ubiquitin
BirA tag ubiquitin BirA tag ubiquitin
BirA tag ubiquitin
BirA tag ubiquitin
ubiquitin BirA ligase
BirA ligase
BirA ligase BirA ligase
E1/E2/E3 enzymatic cascade
substrate protein
A
C
B
Figure 4. Analysis of ubiquitin signaling using bio-ubiquitin. (A) The ubiquitin-biotin-ligase fusion
protein is expressed in the cells of interest. The tagged ubiquitin and the biotin-ligase are processed
co-translationally. (B) The birA-ligase transfers a biotin moiety to the birA tag. (C) The in vivo labeled
bio-ubiquitin is recognized by the E1/E2/E3 conjugation cascade and transferred to the substrate
protein. Additional ubiquitin-moieties are added to the initial ubiquitin forming a poly-ubiquitin-chain.
10. Monitoring Signaling for Specific Enzymes
The identification of enzyme targets is a challenge by itself, and despite the fact that
phosphorylation is one of the best studied post-translational modifications, the substrates of most
human kinases are still unknown. One approach addressing this issue is the use of engineered kinases,
which accept the ATP analogue adenosine-5′-γ-thiophosphate (ATPγS) instead of ATP. Expression of
the modified enzyme leads to target proteins carrying a thio-phospho-group, which in turn can be
used for enrichment by forming a covalent bond with an iodine activated resin. In subsequent steps
the isolated proteins are identified by mass spectrometry. This method has been successfully used in
several studies identifying substrates of the CDK2 or Clk1-cyclin B complex [67,68].
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A similar approach has been developed for the identification of protein-methyltransferase
substrates. These enzymes need S-adenosyl-L-methionine (SAM) as a co-factor, which provides
the methyl group for the methylation reaction. Here, the binding pocket for SAM is mutated to accept
a SAM analogue. Using this technique, methylation targets for GLP1/KMT1D, G9a/KMT1C [69] and
PRMT3 [70] have been identified.
11. Summary and Outlook
Over the last decade, a number of proteomic labeling techniques have been developed, that
range from metabolic labeling with bioorthogonal amino acids, to enzyme-driven modifications
(summarized in Table 1). When choosing a method for protein labeling in vivo, several considerations
regarding possibility for enrichment, cell specificity, and off-target effects, have to be made. Mechanical
separation and sorting of a specific cell type or tissue is straightforward, but no temporal information
is obtained, and the sorting procedure itself can induce proteomic changes. The SILAC methodology
is well established for labeling proteins in cultured cells and whole organisms, but the lack of cell
specificity and enrichment are limitations of the technique. The bioorthogonal amino acids AHA
and HPG can also be utilized by all cell types, but the functional groups of both amino acid analogs
allow the downstream enrichment of labeled proteins. This enables very short labeling times and the
analysis of newly synthesized proteins. Cell specificity of labeling with bioorthogonal amino acids
is achieved by mutated tRNA-synthetases that are engineered to recognize modified amino acids,
but this requires genetic modification of the model system. The same is true for the SORT approach,
where two constructs have to be transferred (engineered tRNA and tRNA synthetase). Advantages
of SORT are that labeling can be extended to any codon, and the speed of the enrichment strategy.
When labeling with bioorthogonal amino acids, side-effects arising from structural differences of
the bioorthogonal amino acids are possible, and in addition, starvation of essential amino acids can
be required. CTAP circumvents these problems by introducing lysine-synthesizing enzymes that
metabolize isotope labeled lysine precursors into heavy labeled L-lysine.
Nascent polypeptides can be labeled with OP-Puro, but the technique has not been widely applied
for proteomics yet. The technique requires genetic transfer of the E. coli enzyme G acylase, and provides
a snapshot of translation at a certain time point.
If labeling of only a subpopulation of proteins in a cell is desired, labeling with a biotinylating
enzyme is the method of choice. Labeling with biotin can either be restricted to a specific protein (BirA
enzyme only biotinylates proteins with an Avi tag) or be applied to all proteins in vicinity to the enzyme
(promiscuous biotin ligase or APEX). In contrast to BioID proximity labeling, labeling with APEX
is very fast, and is also applicable for the labeling of subcellular compartments. For biotin labeling,
genetic modification of the model system is necessary, and care should be taken in choosing a suitable
promoter in order to avoid issues arising from overexpression of the fusion protein. Biotinylation is a
modification that also occurs naturally in vivo, which can create a certain level of background.
Tissue specific labeling techniques can also be used to investigate signaling pathways (qBidS) and
post-translational modifications (ubiquitination, methylation, and phosphorylation). In contrast to
bio-ubiquitination assays, where all ubiquitinated proteins are enriched through affinity purification
of biotinylated ubiquitin, labeling of methylation and phosphorylation sites enables the identification
of kinase and methylase targets. This is achieved by engineering modified enzymes that accept tagged
ATP or SAM analogues, respectively.
The utilization of selective proteome labeling techniques will push the biochemical characterization
of heterogeneous cellular environments to new limits, and help to unravel the complicated signaling
events between different cells types. In the last years, cell-specific labeling has moved from cell culture
to whole model organisms, including mammalian systems.
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Table 1. Labeling Techniques.
Method Label Cell Specific? Genetic ModificationNecessary Already Applied in
Enrichment of Labeled
Proteins Possible Time Scale and Applications References
Stable isotope labeling of
amino acids in cell culture
(SILAC)
heavy isotope containing
amino acids no no
wide range of cell
lines and model
organisms
no
5 doubling times to achieve
complete labeling of a proteome.
Pulsed labeling possible but
number of identifications
is compromised
[1,4–13]
Bioorthogonal labeling of
amino acids in cell culture
(BONCAT)
methione analogues AHA
or HPG no no
wide range of cell
lines and model
organisms
yes (covalent capture with
click chemistry)
short pulses (down to minutes)
and subsequent enrichment of
newly synthesized proteins.
Prolonged labeling possible
[14–17,23–32]
Cell specific BONCAT
biorthogonal amino acids
that require a modified
tRNA sythetase
(azidonorleucine or
p-azido-L-phenylalanine)
yes yes (mutated tRNAsynthetase) cell lines, worm, fly
yes (covalent capture with
click chemistry)
short pulses (down to minutes)
and subsequent enrichment of
newly synthesized proteins.
Prolonged labeling is possible but
dependent on the system side
effects are possible
[18–20,33–37]
Stochastic orthogonal
recoding of translation
(SORT)
bioorthogonal amino acid in
combination with an
orthogonal tRNA and tRNA
synthetase
yes yes (mutated tRNAsynthetase and tRNA)
cell lines, fly,
mouse brain
yes (covalent capture with
click chemistry)
short pulses (down to minutes)
and subsequent enrichment of
newly synthesized proteins.
Prolonged labeling is possible.
Many codons can be tagged
[21,39–41]
O-propargyl-purocmycin
labeling (OP-Puro)
Puromycin analogue
(OP-Puro) binding to
nascent polypeptides
yes yes (penicillin Gacylase ) cell lines
yes (covalent capture with
click chemistry)
very short labeling (minutes).
Provides a snapshot of actively
translated proteins in a cell
[48,49]
isotopic labeling of amino
acid precursors (CTAP)
heavy isotope
containing lysine yes
yes (lysine
synthesizing enzymes) cell lines no
labeling comparable to SILAC.
Cell specific labeling of cells
in co-culture
[44–46]
GFP -labeling and sorting GFP yes yes (GFP) cell lines, unicellularorganisms, mouse
sorting of labeled cells
with FACS
steady state proteome of a
subpopulation of cells [59,60]
proximity-dependent
biotin identification with
a promiscous biotin ligase
(BioID)
biotin yes
yes (promiscous biotin
ligase fused to protein
of interest)
cell lines, unicellular
organisms
yes (affinity purification
with streptavidin)
proximity labeling of
interacting proteins [51–53]
biotinylation with
sequence specific biotin
ligase BirA
biotin yes
yes (BirA and Avi
tagged protein of
interest)
cell lines, wide range
of model organisms
yes (affinity purification
with streptavidin)
biotinylation of tagged proteins
only in cells expressing BirA.
Purification of
interacting proteins
[50]
biotin-ubiquitin yes
yes (Avi tagged
Ubiquitin in fusion
with BirA ligase)
cell lines, fly, mouse yes (affinity purificationwith streptavidin)
biotinylation of ubiquitin and
enrichment of
ubiquitinated proteins
[62–65]
labeling with an
engineered ascorbate
peroxidase (APEX)
biotin phenol yes yes (APEX) cell lines, fly, worm yes (affinity purificationwith streptavidin)
proximity labeling of interacting
proteins or cellular compartment
specific proteins
[54–58]
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